|Bid||9.09 x 800|
|Ask||9.11 x 900|
|Day's range||8.62 - 9.31|
|52-week range||4.41 - 13.53|
|Beta (5Y monthly)||1.12|
|PE ratio (TTM)||N/A|
|Earnings date||30 Oct 2020 - 03 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||9.50|
AMAG Pharmaceuticals (AMAG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AMAG Pharmaceuticals (AMAG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
AMAG (AMAG) posts a narrower-than-expected loss and revenues miss estimates in the second quarter of 2020.